ENSC Stock Analysis: Biotech Pivot & Valuation Risks
ENSC stock price at $0.72, Q1 earnings beat, technicals & forecast. Is ENSC stock a buy for Ensysce Biosciences? Insights on clinical trials & risks. Introduction Ensysce Biosciences develops abuse-deterrent opioids like PF614 for pain management. ENSC stock eyes clinical progress amid biotech funding crunch. Small-caps face volatility from rates and trial risks in tough … Read more